Pep IQ
← Pep IQ
Well-established. GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper) is naturally produced in human plasma — declining from ~200 ng/mL at age 20 to ~80 ng/mL by 60. Maquart, Pickart and colleagues (FEBS Letters 1988; J Investigative Dermatology 2000) demonstrated stimulation of collagen and glycosaminoglycan synthesis in fibroblast cultures and wound healing models. Pickart's later Connectivity Map work suggested modulation of over 4,000 human genes — broad regenerative gene expression including DNA repair, antioxidant defence, and tissue remodelling pathways.
Two distinct routes with different protocols. Topical (skin/hair): 1–2% GHK-Cu solution applied daily, continuous use — well tolerated long-term, no cycling needed because GHK-Cu is endogenous. Subcutaneous (systemic): 1–3 mg/day, often run as 30 days on / 30 days off for cost and to monitor copper status. Some clinical protocols escalate (1 mg days 1–15, 2 mg days 16–30). Local injection near scalp for hair, abdomen for systemic. Stack with BPC-157 / TB-500 in regenerative protocols — different mechanisms (matrix synthesis vs healing signal vs cell migration), complementary effects.
Topical evidence is strong. A 41-woman trial of GHK-Cu eye cream in mild-to-advanced photodamage over 3 months showed reduced lines/wrinkles, improved skin density and thickness vs both placebo and vitamin K cream. Multiple smaller pilot studies show increased skin thickness, elasticity, hydration and collagen density. The Yuvan Research / McGill clinical trial summary reported topical efficacy. Injectable GHK-Cu has not been formally trialled in humans — community SubQ use extrapolates from topical and animal data.
Widely used in cosmetics as Copper Tripeptide-1 — fully accepted as a topical ingredient. Not FDA-approved as an injectable medicine. Sourcing for SubQ via research-peptide vendors. Generally well-tolerated long-term; copper status monitoring is sensible during extended SubQ cycles because GHK-Cu delivers bound copper.
GHK-Cu is one of the safest and best-evidenced peptides for cosmetic and regenerative use, with multiple topical RCTs and decades of cosmetic-industry use. Topical 1–2% solution daily is well-validated for skin and hair. SubQ 1–3 mg/day with cycling is community-derived but consistent with the topical evidence framework. Pep IQ flags this as one of the cleanest entry-points into peptide use — particularly for skin, hair, and as an adjunct to BPC/TB healing protocols. Effects are real but gradual; expect 8–12 weeks before visible changes.
GHK-Cu has one of the most legitimate origin stories in this book. It was first isolated from human plasma in 1973 by biochemist Loren Pickart — who noticed that aged plasma promoted liver cell survival in culture less effectively than young plasma, and traced the difference to this tiny tripeptide. Unlike most peptides in community use, GHK is genuinely endogenous — your body produces it and circulates it, and levels decline with age.
GHK (glycyl-L-histidyl-L-lysine) complexes naturally with copper (Cu²⁺) in the body — the copper complex is the biologically active form. Copper is an essential cofactor for lysyl oxidase and lysyl hydroxylase, the enzymes that cross-link collagen properly. Without adequate copper, newly synthesised collagen is weak. GHK-Cu brings the copper directly to sites that need it.
The peptide is found in the extracellular matrix — GHK sequences are present in the alpha-2(I) chain of type I collagen and can be released by proteases at wound sites. This means wound healing naturally liberates GHK, which then acts as a local repair signal. GHK-Cu has roughly 50 years of published research, has been studied in human clinical trials, and is widely used in cosmetic products — making it one of the best-documented compounds in this book.
GHK-Cu's mechanism operates at multiple levels simultaneously. It is not simply a growth factor or a direct stimulant — it appears to function as a broad gene expression modulator, resetting cellular patterns toward more regenerative states.
The "copper uglies" caveat: Some users of topical copper peptide skincare report a phenomenon called "copper uglies" — an initial period that looks like accelerated skin aging rather than improvement. This is believed to occur because GHK-Cu upregulates MMP-1, which breaks down existing collagen before new collagen is built. If you increase breakdown faster than synthesis, you temporarily look worse before you look better. This effect is anecdotal and not well-studied, but it is consistent with the known MMP mechanism and worth knowing about before starting topical use.